Abstract
Background Parkinson’s disease (PD) is a common movement disorder characterized by bradykinesia, rigidity, and resting tremors. Fatigue is a common disabling symptom but is easily ignored in PD. Half of the PD patients were influenced by fatigue. Acupuncture is one of the conservative treatments for fatigue related to other conditions, especially in China. Therefore, we perform a systematic review and meta-analysis to evaluate the evidence for acupuncture’s effectiveness, safety, and cost benefits for the treatment.
Methods This protocol is based on the previously published randomized controlled trial (RCT) studies. A literature search will be performed on the following database: PubMed, the Cochrane Library, Chinese BioMedical Literature Database, China National Knowledge Infrastructure (CNKI), China Science and Technology Journal Database (VIP), and Wanfang Data. According to the Cochrane Risk of Bias Tool and the level of evidence for results, we will assess the quality of the included studies by using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) method. The Review Manager (v5.3) software will be applied to statistical analysis.
Results From the study, we will assess the effectiveness, safety, and cost-benefit of acupuncture on fatigue relief and functional improvement in patients with Parkinson’s Disease.
PROSPERO registration number CRD42020163155
Strengths and limitations of this study This paper emphasizes the importance of assessing acupuncture in treating Parkinson’s fatigue symptoms and provides methodological guidance for the evaluation of clinical evidence. This study 1) provides a research protocol, 2) facilitates the reasonable evaluation for acupuncture in the treatment of Parkinson’s fatigue symptoms, and 3) raises the potential importance of acupuncture in Parkinson’s fatigue symptoms. Due to the lack of acupuncture reports, there may be a limitation of the small sample size.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Yes
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Not applicable.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
No datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.
Abbreviations
- PD
- Parkinson’s disease
- RCT
- randomized controlled trials
- CNKI
- China National Knowledge Infrastructure
- VIP
- China Science and Technology Journal database
- GRADE
- Grading of Recommendations Assessment, Development, and Evaluation.
